Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

LIAI scientists make important finding on cytomegalovirus transmission

14.05.2007
Finding may have implications for AIDS and other chronic virus infections

Researchers at the La Jolla Institute for Allergy & Immunology have shown that cytomegalovirus (CMV) in the salivary glands can be reduced – and in some cases eliminated – through the use of antibodies to enhance the disease-fighting power of the immune system. The research team’s findings, based on controlled laboratory studies of mice, may also have implications for other chronic virus infections, such as hepatitis and HIV, the virus that causes AIDS.

The team’s findings were published online this week in the Journal of Experimental Medicine in a paper entitled, "Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands." LIAI scientists Ian Humphreys, Ph.D., Carl Ware, Ph.D., and Michael Croft, Ph.D. led the study. CMV is a virus that affects the majority of the world’s population, but produces little or no symptoms in healthy individuals. However, it can cause multi-organ disease in newborns or persons who are immuno-compromised such as organ transplant recipients or AIDS patients.

Ware said, "The main importance of these experiments is identifying the critical molecular targets controlling virus persistence, and two ways in which we can modulate immunity in vivo with the desired result of blocking virus spread to uninfected individuals.

"The potential excitement in the findings is that we may be able to one day use this kind of treatment in humans to block or significantly reduce the spread of cytomegalovirus and other chronic virus infections." Ware noted that the salivary glands are a primary source of transmission for many viruses due to sneezing, coughing and kissing. Eliminating the virus at this critical juncture may significantly reduce CMV’s spread, he said.

In the study, Croft said the research team used an antibody to block the action of the IL-10 protein in the salivary glands of mice by inhibiting binding of IL-10 to its receptor. "IL-10 is a messenger molecule which suppresses the protective T cell response that would normally attack the cytomegalovirus," he said. "By blocking the ability of the IL-10 molecule to bind to its receptor, then you allow these T cells to do their job and reduce or eliminate this virus."

Croft said the scientists also tested a second approach, which used a stimulator antibody in mice to boost the action of the OX40 protein. OX40 helps T cells replicate more quickly, thus building the body’s ability to more effectively battle the virus. "We used this approach to tip the balance in favor of the T cells that would reduce the virus," he said.

The scientists got a stronger result by blocking the IL-10 receptor. "It significantly reduced the virus load in all the animals and in 50 percent of them it completely eliminated it," Croft said. The OX40 treatment also greatly reduced the virus load, but did not eliminate it in any of the animals.

The findings of the Ware and Croft team parallel those of LIAI researcher Matthias von Herrath, M.D., who last year announced that he had successfully eliminated a chronic virus infection in mice by blocking the IL-10 receptor. "Dr. von Herrath’s findings suggested that the IL-10 molecule plays a pretty important role in small RNA viruses, while our study looked at its impact in large DNA viruses," Ware said. "I think both of these studies lend credibility to the idea that the medical community should be looking at IL-10 as a molecular candidate that might be used to control persistent viral infections."

Ware and Croft’s next step will be conducting animal studies with the IL-10 suppression and the OX40 enhancement combined into one treatment. "We tested them separately, but they may well be even more effective when combined," Croft said.

Bonnie Ward | EurekAlert!
Further information:
http://www.liai.org

Further reports about: Chronic Croft Cytomegalovirus IL-10 LIAI OX40 blocking finding glands scientists

More articles from Life Sciences:

nachricht Molecular Force Sensors
20.09.2017 | Max-Planck-Institut für Biochemie

nachricht Foster tadpoles trigger parental instinct in poison frogs
20.09.2017 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Molecular Force Sensors

20.09.2017 | Life Sciences

Producing electricity during flight

20.09.2017 | Power and Electrical Engineering

Tiny lasers from a gallery of whispers

20.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>